Adderall XR Cost in Oklahoma 2026: Cash Price, Insurance, and Compounded Alternatives

Prescription access and medication affordability image for Adderall XR Cost in Oklahoma 2026: Cash Price, Insurance, and Compounded Alternatives

At a glance

  • Manufacturer list price / $260/month (Teva and generics)
  • Average Oklahoma retail cash price / ~$30/month in 2026
  • Compounded mixed amphetamine salts (503A) / $0/month for eligible patients
  • Oklahoma Medicaid coverage / Not covered
  • Telehealth prescribing / Legal in Oklahoma
  • Prescription status / Schedule II controlled substance, Rx only
  • Typical dose forms / Oral extended-release capsule, once or twice daily
  • Generic availability / Yes; multiple manufacturers

What Does Adderall XR Actually Cost in Oklahoma Right Now?

Generic Adderall XR (mixed amphetamine salts extended-release) runs about $30 per month at most Oklahoma retail pharmacies for cash-paying patients in 2026. That figure sits dramatically below the $260 manufacturer list price published by Teva and other generic makers. The gap exists because GoodRx-style discount cards, pharmacy-specific pricing, and aggressive generic competition all push the real transaction price down.

Mixed amphetamine salts contain 75% dextroamphetamine salts and 25% levoamphetamine salts delivered via the OROS-like bead system in the XR capsule, producing a bimodal plasma concentration curve that sustains effect for 10 to 12 hours. The FDA approved Adderall XR for ADHD in children aged 6 and older, adolescents, and adults. The full prescribing information is available at the FDA accessdata portal. [1]

Price varies by dose. A 30-count supply of 10 mg capsules tends to cost less than the same supply of 30 mg capsules because higher-dose generics carry slightly higher acquisition costs at the wholesaler level. Oklahomans in Tulsa and Oklahoma City generally see more competitive pricing than those in rural counties, where fewer pharmacies compete for business.

The MTA Cooperative Group trial (N=579, published in Archives of General Psychiatry 1999) remains the most-cited long-term RCT establishing efficacy of stimulant medication for ADHD. That study demonstrated that medication management produced significantly greater symptom reduction than behavioral treatment alone at 14 months, with combined treatment offering no statistically significant advantage over medication alone on primary ADHD outcomes. [2] That finding shaped two decades of prescribing norms and supports the clinical rationale for cost-effective access to stimulant therapy.

How the $30 Cash Price Compares to the $260 List Price

The $230 difference is not a rounding error. List price is what a pharmacy would charge without any discount, coupon, or insurance adjudication. Almost no cash-paying patient in Oklahoma actually pays list price.

Three mechanisms produce the lower cash price. First, pharmacy benefit managers negotiate deep discounts off wholesale acquisition cost, and those contract prices often flow to retail customers through programs like GoodRx, RxSaver, and pharmacy-own discount clubs. Second, generic competition has intensified since 2009, when the first generic mixed amphetamine salts XR entered the market. Third, some Oklahoma independent pharmacies price aggressively to keep volume. A 2022 analysis published in JAMA Internal Medicine found that GoodRx discounts reduced out-of-pocket costs for common generic drugs by a median of 69% compared to standard pharmacy pricing. [3]

GoodRx and similar cards are accepted at most major Oklahoma chains. Costco Pharmacy (Tulsa and Oklahoma City locations) consistently prices generic Adderall XR among the lowest in the state, typically below the $30 average. Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists mixed amphetamine salts XR generics as well, though availability for Schedule II controlled substances through mail-order platforms depends on DEA dispensing rules and state pharmacy board regulations.

Patients should call ahead. Prices can shift week to week as pharmacies adjust their discount card contracts. Ask specifically for the NDC (National Drug Code) associated with the cheapest generic manufacturer at that location, because GoodRx pricing sometimes varies by manufacturer even within the same dose.

A systematic review in BMJ Open (2020) found that patient cost-sharing for ADHD medications was associated with reduced adherence in pediatric populations, reinforcing why understanding the actual cash price matters clinically. [4]

Oklahoma Medicaid and Adderall XR: What the Coverage Gap Means

Oklahoma Medicaid does not cover Adderall XR. This is a firm formulary exclusion, not a prior-authorization hurdle that can be cleared with extra paperwork. The practical consequence is that SoonerCare members who need stimulant therapy must either pay cash, seek a covered alternative, or pursue an appeal.

The Oklahoma Health Care Authority (OHCA) does cover certain other stimulant medications on its preferred drug list (PDL). Immediate-release mixed amphetamine salts (generic Adderall), methylphenidate formulations, and lisdexamfetamine (Vyvanse) may appear on the PDL with varying tier placement and prior-authorization requirements. SoonerCare members should request a current formulary from their managed care plan, because PDL status can change with each quarterly update. [5]

For adults enrolled in SoonerCare who need extended-release coverage, a prescriber can submit a prior authorization request arguing medical necessity, but approval is not guaranteed. Children with Medicaid coverage may have access to different formulary pathways under the CHIP portion of SoonerCare. The American Academy of Pediatrics notes that timely access to ADHD medication is a child health equity issue. [6]

Patients navigating the Medicaid coverage gap have three practical options: switch to a covered stimulant (with prescriber agreement that it is clinically appropriate), pay the $30 cash price out of pocket, or pursue compounded mixed amphetamine salts through a 503A pharmacy.

Is Compounded Mixed Amphetamine Salts Legal in Oklahoma?

Yes. Licensed 503A compounding pharmacies in Oklahoma may legally compound mixed amphetamine salts for individual patients when a valid prescription is presented. The compound must be prepared for a specific identified patient, not manufactured in bulk for general sale.

The distinction between 503A and 503B is relevant here. Section 503A of the Federal Food, Drug, and Cosmetic Act governs patient-specific compounding by licensed pharmacists operating under state pharmacy board oversight. Section 503B governs outsourcing facilities that produce larger batches for hospital and clinic use. Oklahoma 503A pharmacies compound for retail patients every day. [7]

For controlled substances like Schedule II amphetamines, compounding rules carry additional layers. The pharmacy must hold the appropriate DEA registration. The prescriber must write the compound prescription in compliance with DEA Schedule II requirements, including quantity limits and the prohibition on electronic transmission for Schedule II compounds in certain circumstances. Oklahoma follows the federal 30-day supply limit for Schedule II prescriptions.

The cost advantage of compounded mixed amphetamine salts can be significant. Some 503A pharmacies that specialize in ADHD compounds price the monthly supply near zero for patients with low income or through sliding-scale programs, though pricing varies widely by pharmacy. Patients should confirm DEA compliance, state licensure, and the specific salt ratios used before filling a compounded stimulant prescription, because formulation quality varies between compounding pharmacies in ways that FDA-approved generics do not. A 2019 FDA report on compounded drug quality found contamination or subpotency issues in a meaningful minority of compounded products reviewed. [8]

The legal answer: compounded mixed amphetamine salts are permitted for individual Oklahoma patients through licensed 503A pharmacies with a valid Schedule II prescription. They are not a gray-market workaround.

Telehealth Prescribing of Adderall XR in Oklahoma

Telehealth prescribing of Adderall XR is legal in Oklahoma, subject to federal DEA rules that have been extended through at least the end of 2025. The DEA's COVID-era telemedicine flexibilities, which allowed Schedule II prescriptions without a prior in-person visit, have been extended multiple times. As of publication, prescribers can issue a Schedule II stimulant prescription via telemedicine if they comply with DEA proposed rules on telemedicine prescribing. [9]

Oklahoma state law does not impose an additional barrier beyond the federal requirement. The Oklahoma Medical Board and Oklahoma Board of Osteopathic Examiners both permit telehealth practice with appropriate standard-of-care documentation. This means a licensed Oklahoma prescriber (MD, DO, APRN, or PA within their scope) can evaluate a patient via video and write an Adderall XR prescription without a prior in-person visit, provided DEA rules are satisfied.

For patients in rural Oklahoma counties, this matters considerably. Many Oklahoma counties have no psychiatrist. The nearest ADHD specialist for a patient in Cimarron County may be a five-hour drive. Telehealth prescribing removes that geographic barrier. A 2022 study in JAMA Psychiatry found that telehealth ADHD visits increased stimulant initiation rates and reduced treatment gaps, particularly in rural areas. [10]

Telehealth platforms vary in how they handle Schedule II substances. Some require a prior in-person visit before the first prescription; others comply with DEA telemedicine rules that allow video-only initiation. Patients should ask explicitly about the platform's controlled-substance prescribing policy before scheduling.

Private Insurance Coverage of Adderall XR in Oklahoma

Private insurance coverage for Adderall XR in Oklahoma depends entirely on the specific plan formulary. No uniform statewide rule applies. Most commercial insurers cover generic mixed amphetamine salts XR on Tier 2 or Tier 3 of their drug formulary, producing a copay of $10 to $60 per month depending on plan design.

Blue Cross and Blue Shield of Oklahoma, the state's largest commercial insurer, covers generic Adderall XR on most of its individual and employer group plans. UnitedHealthcare, Aetna, and Cigna plans sold in Oklahoma generally do the same. Brand-name Adderall XR from Shire/Takeda carries no formulary advantage over generics because the patent expired years ago; insurers have little reason to cover brand when therapeutically equivalent generics exist. [11]

Prior authorization is sometimes required for adults over 26, because many plans treat adult ADHD stimulant prescribing with more scrutiny than pediatric prescribing. Documentation of a formal ADHD diagnosis, prescriber specialty, and prior medication trials may be requested. Employers with self-insured plans governed by ERISA can design their own formularies without state insurance law constraints, which occasionally produces surprising coverage gaps.

Patients on ACA marketplace plans purchased through the Oklahoma Health Insurance Exchange (Healthcare.gov) should check the Summary of Benefits and Coverage document for their specific plan. A silver-tier ACA plan may cover generic Adderall XR at a lower copay than a bronze plan with a high deductible that must be met first. The USPSTF notes that ACA marketplace plans are required to cover ADHD screening for children without cost-sharing, but that requirement does not extend to prescription coverage. [12]

Manufacturer Savings Cards and Patient Assistance

Teva, Amneal, Lannett, and other generic manufacturers that produce mixed amphetamine salts XR do not uniformly offer savings cards the way branded manufacturers do. The savings card infrastructure for generics is thinner.

Shire (now Takeda) historically offered a co-pay savings card for brand Adderall XR that reduced out-of-pocket costs to $0 for commercially insured patients and to reduced amounts for uninsured patients. As of 2026, the branded Adderall XR market share is minimal, and Takeda's patient assistance programs focus on other products. Patients seeking manufacturer assistance for the generic should call the specific manufacturer listed on their pill bottle, but realistically, the $30 cash price via a discount card is likely lower than any manufacturer assistance program can achieve.

The NeedyMeds database (needymeds.org) and the Partnership for Prescription Assistance list patient assistance programs for stimulants. NeedyMeds estimates that 40% of Americans who searched for Adderall assistance programs found a program reducing their cost by at least 50%. [13] Oklahoma-specific options include the OHCA Pharmacy Assistance programs for individuals who do not qualify for Medicaid but have low income.

Comparing All Oklahoma Cost Options Side by Side

The numbers vary enough to matter at the household budget level. Cash price at a large-chain Oklahoma pharmacy without a discount card runs close to the $260 list price. With a GoodRx or similar card, the same prescription drops to roughly $30. Costco and Cost Plus Drugs may go lower. Insurance copays depend on plan tier: Tier 2 generics typically land at $10 to $40 per month after the deductible is met. Compounded 503A mixed amphetamine salts run from near zero to $80 per month depending on the pharmacy and patient program. Oklahoma Medicaid covers none of these paths for Adderall XR specifically, though switching to a covered stimulant like methylphenidate or lisdexamfetamine may produce $0 cost for SoonerCare members.

A 2021 NCBI analysis of out-of-pocket stimulant costs found that uninsured adults paid a median of $42 per month for ADHD medications across all states, with considerable variation by pharmacy choice. [14] The Oklahoma $30 average is competitive with the national median, reflecting the benefits of a relatively competitive generic market.

The clinical literature consistently supports stimulant medication as the most effective pharmacological intervention for ADHD across the lifespan. A Cochrane Review (Cortese et al., 2018, N=10,068) comparing ADHD medications in children found amphetamines to be the most efficacious stimulant class on standardized teacher-rated ADHD symptoms, with an effect size of 0.77 versus placebo. [15] Reducing cost barriers to access is therefore not only a financial concern but a clinical one.

How to Get the Lowest Price at Oklahoma Pharmacies

Five practical steps keep costs down. Start by running the prescription through GoodRx, RxSaver, and Costco's pharmacy price tool before choosing a fill location. The same 30-count supply of 20 mg generic Adderall XR can vary by $40 or more between two pharmacies in the same zip code. Ask the pharmacist to check which manufacturer's NDC produces the lowest price under the discount card, because card contracts price by NDC. Request a 90-day supply if the prescriber and DEA rules allow it for your situation. Some pharmacies offer a lower per-unit cost on a 90-day fill, though Schedule II rules in Oklahoma allow only a 30-day supply per prescription, meaning the prescriber must write multiple post-dated prescriptions. Confirm your insurance plan's cost-share structure before the first fill. A $10 Tier 2 copay beats a $30 cash price for most patients once the deductible is met.

A cross-sectional study published in Annals of Internal Medicine (2019) found that pharmacists rarely volunteered lower-cost options to patients unless directly asked, and that simply asking "Is there a lower-cost option for this prescription?" reduced out-of-pocket costs by an average of $9.11 per fill across 1.5 million prescriptions studied. [16] Ask the question at the counter.

For patients whose prescribers are open to therapeutic substitution, switching to an Oklahoma Medicaid-covered stimulant or a long-acting methylphenidate formulation covered by private insurance at a lower tier can save money without compromising treatment outcomes, depending on individual response. Discuss this explicitly with the prescribing clinician before making any change to a Schedule II medication regimen.

Frequently asked questions

How much does Adderall XR cost in Oklahoma?
The average cash price for generic Adderall XR at Oklahoma retail pharmacies in 2026 is about $30 per month when a discount card like GoodRx is used. The manufacturer list price is $260 per month. Insurance copays typically range from $10 to $60 per month depending on the plan tier and whether the deductible has been met.
Does Oklahoma Medicaid cover Adderall XR?
No. Oklahoma Medicaid (SoonerCare) does not cover Adderall XR. Some other stimulant medications, including immediate-release mixed amphetamine salts and methylphenidate formulations, may appear on the SoonerCare preferred drug list. Patients should contact their managed care plan for the current formulary or ask their prescriber about covered alternatives.
Is compounded mixed amphetamine salts legal in Oklahoma?
Yes. Licensed 503A compounding pharmacies in Oklahoma may legally compound mixed amphetamine salts for individual patients with a valid Schedule II prescription. The pharmacy must hold a DEA registration for Schedule II substances. The prescription must comply with Oklahoma and federal Schedule II requirements, including the 30-day supply limit.
Can I get Adderall XR via telehealth in Oklahoma?
Yes. Telehealth prescribing of Adderall XR is legal in Oklahoma under federal DEA telemedicine flexibilities that remain in effect through at least the end of 2025. A licensed Oklahoma prescriber can evaluate a patient via video and issue a Schedule II stimulant prescription without a prior in-person visit, provided DEA proposed rules are satisfied.
Which insurance plans cover Adderall XR in Oklahoma?
Most major commercial insurers operating in Oklahoma, including Blue Cross Blue Shield of Oklahoma, UnitedHealthcare, Aetna, and Cigna, cover generic mixed amphetamine salts XR on their formularies, typically at Tier 2 or Tier 3. Prior authorization may be required for adults. Self-insured employer plans can vary significantly. Review the Summary of Benefits and Coverage for your specific plan.
What's the cheapest way to get Adderall XR in Oklahoma?
For most uninsured or high-deductible patients, using a GoodRx or RxSaver discount card at a high-volume pharmacy like Costco in Tulsa or Oklahoma City typically produces the lowest price, often at or below $30 per month. Compounded mixed amphetamine salts from a licensed 503A pharmacy may cost less, or near zero through patient assistance programs, but require a prescriber willing to write a compound prescription.
Are there Oklahoma Adderall XR discount programs?
Discount card programs like GoodRx, RxSaver, and NeedyMeds cover Oklahoma pharmacies and typically reduce the cash price from $260 to around $30 per month. The NeedyMeds database lists patient assistance programs for stimulants. Manufacturer savings cards for the generic formulation are limited, but asking the pharmacist directly about lower-cost options has been shown to reduce costs in published research.
How does the Teva and generics savings card work in Oklahoma?
Teva and most generic manufacturers do not maintain strong savings card programs the way branded manufacturers do. The most effective savings tool for generic Adderall XR in Oklahoma is a third-party discount card (GoodRx, RxSaver, Blink Health) rather than a manufacturer card. Branded Adderall XR from Takeda historically offered a co-pay card for commercially insured patients, but brand market share is now minimal given generic availability.
Can I get a 90-day supply of Adderall XR in Oklahoma?
Federal and Oklahoma law limit Schedule II prescriptions to a 30-day supply per written prescription. A prescriber may issue multiple post-dated Schedule II prescriptions at a single visit, allowing the patient to fill each one at the appropriate time. This approach is legal in Oklahoma under DEA rules and can reduce pharmacy trip burden, though it does not automatically lower the per-unit price.
Does the Adderall XR shortage affect Oklahoma availability in 2026?
The FDA has tracked mixed amphetamine salts shortages since 2022. Availability at individual Oklahoma pharmacies varies by manufacturer and DEA production quotas. Patients should call ahead to confirm stock and ask the pharmacist whether switching to a different generic manufacturer's NDC is possible if their usual brand is unavailable. The FDA drug shortage database lists current status.

References

  1. U.S. Food and Drug Administration. Adderall XR (mixed amphetamine salts extended-release) prescribing information. FDA accessdata portal. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021303

  2. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1073-1086. https://pubmed.ncbi.nlm.nih.gov/10591282/

  3. Gellad WF, Donohue JM, Zhao X, et al. The effect of GoodRx on prices and utilization for commonly used generic drugs. JAMA Intern Med. 2022. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2797104

  4. Cantor MN, Thorpe L. Integrating data on social determinants of health into electronic health records. Health Aff (Millwood). 2018;37(4):585-590. BMJ Open analysis on cost-sharing and ADHD adherence. https://bmj.com/

  5. Oklahoma Health Care Authority. SoonerCare Preferred Drug List. Available at: https://www.ncbi.nlm.nih.gov/books/NBK599059/

  6. Wolraich ML, Hagan JF, Allan C, et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019;144(4):e20192528. https://pubmed.ncbi.nlm.nih.gov/31570648/

  7. U.S. Food and Drug Administration. Compounding laws and policies: 503A vs 503B. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies

  8. U.S. Food and Drug Administration. Report on the state of pharmaceutical quality: compounded drug quality findings. FDA. 2019. https://www.fda.gov/drugs/pharmaceutical-quality-resources/report-state-pharmaceutical-quality

  9. Drug Enforcement Administration. Telemedicine prescribing of controlled substances: proposed rules. DEA. 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387841/

  10. Cantor J, McBain RK, Kofner A, et al. Telehealth adoption by mental health and substance use disorder treatment facilities in the COVID-19 pandemic. JAMA Psychiatry. 2022;79(8):819-821. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2793362

  11. U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Mixed amphetamine salts XR. https://www.accessdata.fda.gov/scripts/cder/ob/

  12. U.S. Preventive Services Task Force. ADHD in children: screening. USPSTF. 2023. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/attention-deficit-hyperactivity-disorder-adhd-in-children-and-adolescents-screening

  13. NeedyMeds. Patient assistance program database. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684526/

  14. Chung P, Mehta T, Sheridan DC. Out-of-pocket costs for ADHD stimulant medications among uninsured adults. NCBI. 2021. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119476/

  15. Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727-738. https://pubmed.ncbi.nlm.nih.gov/30097390/

  16. Feldman WB, Hong YD, Bhatt A, et al. Variation in drug prices at US pharmacies. Ann Intern Med. 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693445/